CRLF3 plays a key role in the final stage of platelet genesis and is a potential therapeutic target for thrombocythemia. (2022)
Attributed to:
Generating platelets in vitro for the clinic: optimisation and added clinical efficacy
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.17863/cam.78642
Publication URI: https://www.repository.cam.ac.uk/handle/1810/331195
Type: Journal Article/Review